Abstract: Compounds useful for molecular imaging of cells expressing estrogen receptors are provided. Also provided are intermediates for making the compounds and methods of making the compounds using a modular convergent strategy. Further, methods of making the intermediates are described, as well as methods of diagnosing disease in a subject by using the compounds as imaging agents.

Abstract: An organic EL element including: an anode and a cathode disposed to face each other with a gap therebetween; a functional layer that contains an organic material and is disposed between the anode and the cathode; and an electron injection layer that has a function to inject electrons into the functional layer and is disposed between the anode and the cathode. The electron injection layer contains a metal oxide with d0 electron configuration, and a Fermi level of the electron injection layer is located in a vicinity of a lower end of a conduction band of the electron injection layer.

Abstract: Compounds useful for molecular imaging of cells expressing estrogen receptors are provided. Also provided are intermediates for making the compounds and methods of making the compounds using a modular convergent strategy. Further, methods of making the intermediates are described, as well as methods of diagnosing disease in a subject by using the compounds as imaging agents.

Abstract: An organic EL element including: an anode and a cathode disposed to face each other with a gap therebetween; a functional layer that contains an organic material and is disposed between the anode and the cathode; and an electron injection layer that has a function to inject electrons into the functional layer and is disposed between the anode and the cathode. The electron injection layer contains a metal oxide with d0 electron configuration, and a Fermi level of the electron injection layer is located in a vicinity of a lower end of a conduction band of the electron injection layer.

Abstract: A medical device, such as, for example, a catheter, includes a tubular member having a first portion having a shape memory polymer.

Abstract: An embolic protection filter assembly and method of making the same. In at least some embodiments, the present invention relates to embolic protection filters having at least one radiopaque component.

Abstract: The present invention includes systems, methods and apparatus. A system in accord with the present invention may include an intraluminal patch sized to fit within a lumen and an expandable therapeutic delivery device. The patch in this embodiment may have an adhesive region on an exposed surface and a drug reservoir region in communication with the exposed surface. By comparison, a method employing the present invention may include placing an intraluminal patch over an expandable delivery device, advancing the delivery device and the expandable patch to a target site, expanding the delivery device so that the patch adheres to the target site, and contracting and withdrawing the delivery device. In so doing the patch may remain to emit a drug to the target site over a sustained period of time.

Abstract: The present invention provides novel adenosine receptor antagonists, more particularly, A1 adenosine receptor antagonists. Pharmaceutical compositions comprising an A1 adenosine receptor antagonist disclosed herein and a pharmaceutically acceptable carrier are further provided. Compositions also include diagnostic assay-type probes comprising a novel A1 adenosine receptor antagonist that is labeled or conjugated with radioactive or non-radioactive material. Methods for treating A1 adenosine receptor related disorders comprising administering an A1 adenosine receptor antagonist of the invention are also disclosed. The novel A1 adenosine receptor antagonist compositions find further use in diagnostic and imaging methods.

Abstract: An endoprosthesis comprising a stent, a cover fully covering the stent wherein the cover has variable porosity in the radial direction; and an adhesion layer connecting the stent to the cover. Another aspect of the invention is a method of implanting an endoprosthesis which includes a stent, providing a cover with variable porosity in the radial direction, connecting the stent to the cover with an adhesion layer to form a covered stent, and implanting the covered stent within a body lumen of a patient.

Abstract: A catheter comprises a catheter shaft, at least a portion of which defines a medical device receiving region, and at least one sleeve. The at least one sleeve comprises a tubular member constructed and arranged to transition between an extended state and a retracted state. The tubular member has a first portion being engaged to a portion of the catheter shaft adjacent to the medical device receiving region. In the extended state a second portion is constructed and arranged to at least partially overlay the medical device receiving region. In the retraced state the second portion is removed from about the medical device receiving region. At least one of the first portion and the second portion of the tubular member are at least partially constructed from a shape memory material.

Abstract: A medical device, such as, for example, a catheter, includes a tubular member having a first portion having a shape memory polymer.

Abstract: A medical device comprising a substrate and a hydrogel coating disposed over at least a portion of the substrate surface. The hydrogel coating contains an MRI contrast agent and includes inner and outer regions. The inner region comprises a first hydrogel polymer, and the outer region comprises a second hydrogel polymer that can be the same as or different from the first hydrogel polymer. The inner region exhibits more absorption upon hydration than does the outer region. Examples of hydrogel polymers include polysaccharide and polypeptide hydrogel polymers such as alginic acid, hyaluronic acid, chitin, carboxymethyl cellulose, hydroxypropyl cellulose, collagen, and gelatin, as well as salts and copolymers thereof. Upon insertion or implantation of the medical device into a patient, the hydrogel coating is differentiable from the environment surrounding the hydrogel coating under magnetic resonance imaging.